Sionna Therapeutics, Inc. (SION)
Every FINRA and SEC series the site collects for Sionna Therapeutics, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
4.2M
Short interest
settlement 2026-08-14
1.0
Days to cover
+1.2% vs prior
44.5%
Short share of volume
2026-09-11
13,771
Fails to deliver
settlement 2026-08-14
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 37 settlements in the JSONAs of 14 August 2026, short interest in SION is 4,247,834 shares, down 1,009,443 shares over the last month. Over the last 37 readings it ranged from 630,656 shares (14 February 2025) to 5,522,307 shares (30 June 2026). At the reported average volume of 7.4M shares a day that is 1.0 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/sion" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 4,247,834 | +1.2% | 7,351,935 | 1.00 |
| 2026-07-31 | 4,198,394 | -20.1% | 618,000 | 6.79 |
| 2026-07-15 | 5,257,277 | -4.8% | 456,753 | 11.51 |
| 2026-06-30 | 5,522,307 | +10.5% | 544,387 | 10.14 |
| 2026-06-15 | 4,996,300 | +7.7% | 360,220 | 13.87 |
| 2026-05-29 | 4,639,069 | -2.1% | 319,204 | 14.53 |
| 2026-05-15 | 4,740,815 | +12.1% | 421,449 | 11.25 |
| 2026-04-30 | 4,230,439 | +11.3% | 455,368 | 9.29 |
| 2026-04-15 | 3,799,971 | +1.1% | 446,313 | 8.51 |
| 2026-03-31 | 3,756,705 | +6.0% | 332,759 | 11.29 |
| 2026-03-13 | 3,544,166 | +5.8% | 287,319 | 12.34 |
| 2026-02-27 | 3,350,255 | +9.3% | 143,394 | 23.36 |
| 2026-02-13 | 3,064,857 | -2.5% | 407,220 | 7.53 |
| 2026-01-30 | 3,143,560 | +2.9% | 231,949 | 13.55 |
| 2026-01-15 | 3,053,667 | -6.3% | 312,305 | 9.78 |
| 2025-12-31 | 3,258,091 | +13.3% | 384,534 | 8.47 |
| 2025-12-15 | 2,876,610 | +0.5% | 289,353 | 9.94 |
| 2025-11-28 | 2,862,557 | -3.7% | 266,254 | 10.75 |
| 2025-11-14 | 2,973,430 | +0.3% | 194,700 | 15.27 |
| 2025-10-31 | 2,965,776 | -12.1% | 364,626 | 8.13 |
| 2025-10-15 | 3,372,058 | -14.2% | 299,618 | 11.25 |
| 2025-09-30 | 3,931,123 | +4.2% | 330,552 | 11.89 |
| 2025-09-15 | 3,771,820 | +8.5% | 306,321 | 12.31 |
| 2025-08-29 | 3,475,743 | -3.5% | 197,588 | 17.59 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of SION volume is 44.5%, up 13.4 points over the last five sessions. Over the last 52 readings it ranged from 20.2% (11 August 2026) to 71.8% (7 August 2026). The latest reading is in line with the 30-session average of 43.1%, on 486K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 216K | 486K | 44.5% | 30,039 |
| 2026-09-10 | 285K | 498K | 57.1% | 0 |
| 2026-09-09 | 127K | 310K | 41.0% | 711 |
| 2026-09-08 | 151K | 394K | 38.4% | 0 |
| 2026-09-04 | 121K | 375K | 32.3% | 8,244 |
| 2026-09-03 | 178K | 571K | 31.2% | 2,660 |
| 2026-09-02 | 295K | 670K | 44.1% | 2,022 |
| 2026-09-01 | 216K | 566K | 38.3% | 453 |
| 2026-08-31 | 134K | 311K | 43.1% | 202 |
| 2026-08-28 | 86K | 238K | 36.0% | 0 |
| 2026-08-27 | 105K | 378K | 27.8% | 26 |
| 2026-08-26 | 153K | 431K | 35.6% | 0 |
| 2026-08-25 | 208K | 857K | 24.2% | 3,700 |
| 2026-08-24 | 312K | 885K | 35.3% | 1,270 |
| 2026-08-21 | 342K | 851K | 40.2% | 50,882 |
| 2026-08-20 | 359K | 708K | 50.7% | 25,126 |
| 2026-08-19 | 228K | 627K | 36.4% | 1,656 |
| 2026-08-18 | 413K | 1.0M | 41.3% | 2,561 |
| 2026-08-17 | 560K | 1.4M | 39.2% | 15,383 |
| 2026-08-14 | 389K | 1.2M | 33.3% | 8,575 |
| 2026-08-13 | 990K | 2.6M | 37.5% | 15,875 |
| 2026-08-12 | 1.2M | 5.3M | 21.6% | 29,995 |
| 2026-08-11 | 1.5M | 7.2M | 20.2% | 151,787 |
| 2026-08-10 | 11.1M | 19.2M | 57.7% | 1,343,106 |
| 2026-08-07 | 255K | 355K | 71.8% | 3,397 |
| 2026-08-06 | 202K | 355K | 57.0% | 3 |
| 2026-08-05 | 193K | 288K | 67.0% | 0 |
| 2026-08-04 | 316K | 509K | 62.0% | 100 |
| 2026-08-03 | 158K | 249K | 63.5% | 0 |
| 2026-07-31 | 107K | 161K | 66.0% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in SION is 13,771 shares, up 10,363 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (5 March 2026) to 120,409 shares (29 June 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 13,771 | $6.54 | $90K |
| 2026-08-13 | 3,408 | $6.25 | $21K |
| 2026-08-12 | 498 | $5.10 | $3K |
| 2026-08-11 | 2,315 | $4.50 | $10K |
| 2026-08-05 | 3 | $49.94 | $150 |
| 2026-08-04 | 1 | $49.26 | $49 |
| 2026-08-03 | 11 | $47.13 | $518 |
| 2026-07-29 | 1,736 | $46.55 | $81K |
| 2026-07-16 | 908 | $44.38 | $40K |
| 2026-07-07 | 13 | $43.12 | $561 |
| 2026-07-06 | 3,753 | $43.99 | $165K |
| 2026-07-02 | 7,391 | $41.64 | $308K |
| 2026-06-30 | 9,681 | $42.97 | $416K |
| 2026-06-29 | 120,409 | $42.18 | $5.1M |
| 2026-06-25 | 1,101 | $41.09 | $45K |
| 2026-06-24 | 1,886 | $39.87 | $75K |
| 2026-06-23 | 90 | $38.83 | $3K |
| 2026-06-22 | 66 | $37.30 | $2K |
| 2026-06-15 | 353 | $35.92 | $13K |
| 2026-06-12 | 186 | $36.05 | $7K |
| 2026-06-10 | 24,749 | $33.69 | $834K |
| 2026-04-29 | 615 | $39.59 | $24K |
| 2026-04-28 | 1,307 | $39.21 | $51K |
| 2026-04-27 | 30 | $38.11 | $1K |
| 2026-04-22 | 6 | $41.79 | $251 |
| 2026-04-20 | 460 | $43.54 | $20K |
| 2026-04-17 | 721 | $45.24 | $33K |
| 2026-04-16 | 6,569 | $45.09 | $296K |
| 2026-04-14 | 397 | $41.77 | $17K |
| 2026-04-13 | 2,168 | $37.89 | $82K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONNo open-market insider trades were reported for SION in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Thompson Peter A. on 2026-05-27.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Thompson Peter A. | n/a | Sell | 101 | $44.49 | $4K | 2.7M |
| 2026-05-27 | ORBIMED ADVISORS LLC | n/a | Sell | 101 | $44.49 | $4K | 2.7M |
| 2026-05-11 | Thompson Peter A. | n/a | Sell | 185K | $46.22 | $8.5M | 2.7M |
| 2026-05-11 | ORBIMED ADVISORS LLC | n/a | Sell | 185K | $46.22 | $8.5M | 2.7M |
| 2026-05-08 | Thompson Peter A. | n/a | Sell | 60K | $44.58 | $2.7M | 2.9M |
| 2026-05-08 | ORBIMED ADVISORS LLC | n/a | Sell | 60K | $44.58 | $2.7M | 2.9M |
| 2026-05-07 | Thompson Peter A. | n/a | Sell | 49K | $44.61 | $2.2M | 2.9M |
| 2026-05-07 | ORBIMED ADVISORS LLC | n/a | Sell | 49K | $44.61 | $2.2M | 2.9M |
| 2026-04-18 | Thompson Peter A. | n/a | Sell | 3K | $44.52 | $131K | 3.0M |
| 2026-04-18 | ORBIMED ADVISORS LLC | n/a | Sell | 3K | $44.52 | $131K | 3.0M |
| 2026-04-17 | Thompson Peter A. | n/a | Sell | 52K | $44.68 | $2.3M | 3.0M |
| 2026-04-17 | ORBIMED ADVISORS LLC | n/a | Sell | 52K | $44.68 | $2.3M | 3.0M |
| 2026-04-16 | Thompson Peter A. | n/a | Sell | 227K | $45.34 | $10.3M | 3.0M |
| 2026-04-16 | ORBIMED ADVISORS LLC | n/a | Sell | 227K | $45.34 | $10.3M | 3.0M |
| 2026-04-15 | Thompson Peter A. | n/a | Sell | 236K | $44.64 | $10.5M | 3.2M |
| 2026-04-15 | ORBIMED ADVISORS LLC | n/a | Sell | 236K | $44.64 | $10.5M | 3.2M |
| 2026-04-14 | Thompson Peter A. | n/a | Sell | 48K | $44.51 | $2.1M | 3.5M |
| 2026-04-14 | ORBIMED ADVISORS LLC | n/a | Sell | 48K | $44.51 | $2.1M | 3.5M |
| 2026-03-05 | Fitzpatrick Jennifer | Chief Legal Officer | Sell | 10K | $33.86 | $347K | 0 |
| 2026-03-05 | Fitzpatrick Jennifer | Chief Legal Officer | Option exercise | 10K | $6.11 | $63K | 10K |
| 2026-02-03 | Thompson Peter A. | n/a | Sell | 29K | $44.58 | $1.3M | 3.5M |
| 2026-02-03 | ORBIMED ADVISORS LLC | n/a | Sell | 29K | $44.58 | $1.3M | 3.5M |
| 2026-02-02 | Thompson Peter A. | n/a | Sell | 2K | $44.57 | $84K | 3.6M |
| 2026-02-02 | ORBIMED ADVISORS LLC | n/a | Sell | 2K | $44.57 | $84K | 3.6M |
| 2026-01-22 | TPG GP A, LLC | n/a | Sell | 250K | $40.00 | $10.0M | 6.5M |
| 2025-12-24 | Thompson Peter A. | n/a | Sell | 33K | $44.55 | $1.5M | 3.6M |
| 2025-12-24 | ORBIMED ADVISORS LLC | n/a | Sell | 33K | $44.55 | $1.5M | 3.6M |
| 2025-12-19 | Thompson Peter A. | n/a | Sell | 875 | $44.49 | $39K | 3.6M |
| 2025-12-19 | ORBIMED ADVISORS LLC | n/a | Sell | 875 | $44.49 | $39K | 3.6M |
| 2025-12-18 | Thompson Peter A. | n/a | Sell | 100 | $44.49 | $4K | 3.6M |
| 2025-12-18 | ORBIMED ADVISORS LLC | n/a | Sell | 100 | $44.49 | $4K | 3.6M |
| 2025-12-17 | Thompson Peter A. | n/a | Sell | 900 | $44.50 | $40K | 3.6M |
| 2025-12-17 | ORBIMED ADVISORS LLC | n/a | Sell | 900 | $44.50 | $40K | 3.6M |
| 2025-12-05 | Fitzpatrick Jennifer | Chief Legal Officer | Sell | 10K | $40.52 | $415K | 0 |
| 2025-12-05 | Fitzpatrick Jennifer | Chief Legal Officer | Option exercise | 10K | $6.11 | $63K | 10K |
| 2025-11-26 | Thompson Peter A. | n/a | Sell | 2K | $44.49 | $71K | 3.6M |
| 2025-11-26 | ORBIMED ADVISORS LLC | n/a | Sell | 2K | $44.49 | $71K | 3.6M |
| 2025-11-25 | Thompson Peter A. | n/a | Sell | 12K | $44.60 | $530K | 3.6M |
| 2025-11-25 | ORBIMED ADVISORS LLC | n/a | Sell | 12K | $44.60 | $530K | 3.6M |
| 2025-11-24 | Thompson Peter A. | n/a | Sell | 95K | $44.54 | $4.2M | 3.6M |
| 2025-11-24 | ORBIMED ADVISORS LLC | n/a | Sell | 95K | $44.54 | $4.2M | 3.6M |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 8K | $39.50 | $301K | 159K |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 6K | $39.50 | $254K | 2.2M |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 10K | $39.50 | $392K | 650K |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 1K | $39.50 | $48K | 6.9M |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 604 | $40.50 | $24K | 167K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 512 | $40.50 | $21K | 2.2M |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 788 | $40.50 | $32K | 660K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 96 | $40.50 | $4K | 6.9M |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | n/a | Sell | 947 | $39.89 | $38K | 167K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
13F holders
Tracked managers holding SION at their latest 13F. JSON5 of the 30 tracked managers held SION at their latest 13F, $212.4M in total at quarter-end prices. Viking Global Investors is the largest at $140.6M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Viking Global Investors | 2026-06-30 | 3.2M | $140.6M | 0.40% | 0 |
| Citadel Advisors | 2026-06-30 | 1.2M | $50.9M | 0.01% | -11K |
| Millennium Management | 2026-06-30 | 325K | $14.3M | 0.01% | +185K |
| D. E. Shaw & Co. | 2026-06-30 | 102K | $4.5M | 0.00% | +96K |
| Point72 Asset Management | 2026-06-30 | 49K | $2.2M | 0.00% | -87K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Sionna Therapeutics, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Sionna Therapeutics, Inc. (SION), SEC CIK 2036042, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-05-27.JSON and CSV
- Company record
- EDGAR filing index for CIK 2036042Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
- UTHRUNITED THERAPEUTICS Corp
- CPIXCUMBERLAND PHARMACEUTICALS INC
- LLYELI LILLY & Co
- ALNYALNYLAM PHARMACEUTICALS, INC.
- PTCTPTC THERAPEUTICS, INC.
- MDGLMADRIGAL PHARMACEUTICALS, INC.
- ONCBeOne Medicines Ltd.
- IONSIONIS PHARMACEUTICALS INC
- INSMINSMED Inc
- CORTCORCEPT THERAPEUTICS INC
- BBIOBridgeBio Pharma, Inc.
- ROIVRoivant Sciences Ltd.
- CYTKCYTOKINETICS INC
- LGNDLIGAND PHARMACEUTICALS INC
- VRTXVERTEX PHARMACEUTICALS INC / MA
- LQDALiquidia Corp
- BLTEBELITE BIO, INC
- TVTXTravere Therapeutics, Inc.
- PAHCPHIBRO ANIMAL HEALTH CORP
- ARQTArcutis Biotherapeutics, Inc.
- HOWLWerewolf Therapeutics, Inc.
- NATRNATURES SUNSHINE PRODUCTS INC
- JNJJOHNSON & JOHNSON
- BMYBRISTOL MYERS SQUIBB CO
Datasets
Frequently Asked Questions
How much of SION is sold short?
What is SION's daily short volume?
Does SION have fails to deliver?
Are SION insiders buying or selling?
Which funds hold SION?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.